Kennedy, Donna L.
Ridout, Deborah
Lysakova, Ladislava
Vollert, Jan
Alexander, Caroline M.
Rice, Andrew S. C.
Article History
Received: 31 August 2021
Accepted: 25 October 2021
First Online: 17 November 2021
Declarations
:
: Ethical approval was granted by the Camberwell St Giles National Research Ethics Committee (14/LO/1436) on 29 August 2014. Participants provided informed, written consent for participation.
: Participants provided informed, written consent for publication.
: A.S.C. Rice: IASP Council Member and Chair 18th World Congress on Pain Scientific Programme Committee; A.S.C.R undertakes consultancy and advisory board work for Imperial College Consultants—in the past 24 months this has included remunerated work for Abide, Pharmanovo, Lateral, Novartis, Pharmaleads, Mundipharma, Orion, Asahi Kasei, Toray, and Theranexis; ASCR was the owner of share options in Spinifex Pharmaceuticals, from which personal benefit was accrued on the acquisition of Spinifex by Novartis in July 2015 and from which payments continued until 2019. ASCR is named as an inventor on the following patents: (1) A.S.C. Rice, S. Vandevoorde and D.M. Lambert Methods using N-(2-propenyl) hexadecanamide and related amides to relieve pain. WO 2005/079771. (2) Okuse K. et al. Methods of treating pain by inhibition of vgf activity EP13702262.0/WO2013 110945. Jan Vollert: personal fees from Vertex Pharmaceuticals, personal fees from Embody Orthopaedic, outside the submitted work. The remaining authors have no conflicts of interest to declare.